Biomarkers for memory decline after brain hemorrhage
Treatments studied
Part of Brain & nervous system clinical trials.
This study looks for biological signs that might predict memory problems after a brain bleed, which could help doctors provide better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a brain bleed (intracerebral hemorrhage)
- You are between 18 and 79 years old
- You do not already have dementia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain markers in your blood can help predict how someone will recover from a type of stroke called intracerebral hemorrhage (bleeding inside the brain). If you are between 25 and 40 and have symptoms of this condition, you may be eligible to join.
This study looks for markers in your blood and brain scans that may help doctors better understand and predict outcomes after a spontaneous brain bleed. It is for people with high blood pressure who have had a bleed within the last three days.
This study is testing whether certain substances in your blood can help doctors better detect and understand problems with blood flow in the brain. Researchers hope these new 'biomarkers' could lead to faster and more accurate diagnosis of conditions like stroke and mini-stroke.
This study looks at brain swelling (“cerebral edema”) after a spontaneous brain bleed and how it relates to outcomes. It mainly involves people who can have early care and MRI scans, to better understand what affects recovery.
This study looks for “biomarkers” (measurable signs from blood and brain tests) that may help predict who with mild cognitive impairment (MCI) could later develop dementia. Results may help doctors spot risk earlier and better plan care.
This study looks at people who come to the emergency room with a bleeding stroke (called intracerebral hemorrhage). It aims to learn more about the condition by studying blood tests and brain scans, to find ways to improve outcomes.
Hear when a new Primary Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.